IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,453,734 | +56.1% | 319,502 | +141.6% | 0.17% | +10.4% |
| Q2 2023 | $931,033 | +158.6% | 132,249 | +124.4% | 0.15% | +105.3% |
| Q1 2023 | $360,026 | -73.2% | 58,924 | -72.0% | 0.08% | -78.6% |
| Q4 2022 | $1,344,456 | +173.8% | 210,400 | +310.9% | 0.35% | +258.2% |
| Q3 2022 | $491,000 | -58.0% | 51,206 | -51.6% | 0.10% | -79.2% |
| Q2 2022 | $1,168,000 | +244.5% | 105,780 | +418.9% | 0.47% | +946.7% |
| Q1 2022 | $339,000 | -78.7% | 20,386 | -68.4% | 0.04% | -70.6% |
| Q3 2021 | $1,592,000 | -4.3% | 64,556 | +0.9% | 0.15% | -34.3% |
| Q2 2021 | $1,664,000 | +545.0% | 63,956 | +580.6% | 0.23% | +23.3% |
| Q2 2020 | $258,000 | -17.0% | 9,397 | -66.0% | 0.19% | +894.7% |
| Q3 2018 | $311,000 | – | 27,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |